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A BSTRACT
From a clinical point o f view, differentiation o f numerous form s o f m igraine depends on the accompanying 
diseases with prevailing cardiovascular sym ptom s. However, many pathophysiological interactions between 
migraine and cardiovascular disturbances remain insufficiently clarified yet. During the fits o f m igraine, the 
patients complain from palpitation, angina pectoris, tachycardia, anxiety, and feeling o f fear. ECG exam ina­
tion reveals non-specific changes o f T-wave and either elevation, or reduction o f ST-segm ent. It has been sup­
posed that the fit is due to a spasm of coronary vessels (‘coronary m igraine'). In m igraine patients, there is a 
relationship between serotonin (5-HT) and the sym pathetic nerves under pathological conditions. During the 
period between the m igraine seizures there is an increase by two tim es but during the seizure itself by four 
times of the plasma levels o f  norepinephrine, serum  dopam ine, beta-hydroxylase, systolic and diastolic arte­
rial blood pressure and heart rate in com parison with these param eters in healthy controls. The new class of 
5-HT IB /ld  antagonists and ergotam ine as well can induce vasoconstriction by stim ulation o f 5-HT receptors 
of the peripheral vessels. The low relative share of myocardial infarctions in m igraine patients along with the 
higher one of angina pectoris results from the coronary spasm accom panying every m igraine fit and from the 
increased arterial resistance. There is a familial predisposition between m igraine and Raynaud’s disease, sys­
temic lupus erythematosus, and acute m yocardial infarction as risk factor for the manifestation o f migraine 
fits. Coronary ischemia plays an im portant role in these cases and requires the discussion o f an adequate ther­
apeutic and protective approach.
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IN TRO DUCTIO N
Nature and duration o f neurological symptoms are o f  es­
sential clinical value when differentiating the numerous 
forms of migraine. This point o f view is important for the 
analysis o f the accompanying somatic diseases and espe­
cially of those with prevailing cardiovascular symptoms. 
Knowledge and clinical experience in this field define the 
indications and contraindications in the treatment o f mi­
graine (3,5).
Biochemistry of migraine
Biochemical and pathobiochemical relations between mi­
graine and cardiovascular diseases.
Circulating serotonin (5-hydroxytryptamine, 5-HT) accu­
mulated in platelets plays a neurotransmitter role in the 
bmin. Laider certain circumstances, it is capable o f  influ­
encing upon the vascular wall (7). Amines are involved in 
the regulation o f  vascular tone by acting on the cardiovas­
cular receptors and activating them either towards
\ddress for correspondence:
/1 Minchev, Second Clinic o f Neurology, Dept, o f Neurology. Prof. P. 
S/ownov I am i University o f Medicine. 55 Mann Drinov St.. 
BG-9005 I'aiva, Bulgaria 
e-mail: tlmm neuro(Æyahoo.co.uk
vasodilatation, or towards vasoconstriction. It has been 
shown that 5-HT is metabolized or accumulated in the en­
dothelial cells close to tire sympathetic nerve endings. The 
barrier ftmction o f  endothelium prevents the penetration o f 
vasoactive substances such as 5-HT into the vascular wall 
while, at capillary level, the endothelial cell hampers their 
penetration through the tissues playing the role o f  
blood-brain barrier (16). Tire role o f  5-HT to pass, to accu­
mulate and, when possible, to liberate itself in tire endings 
o f  tire sympathetic nerves is clarified. The sympathetic 
nerves regulate the blood flow in the vessels in dependence 
o f  5-HT variations as the outcome can be reversible.
Some recent investigations suggest a relationship between 
5-HT and tire sympathetic nerves under pathological condi­
tions. For instance, tire increase o f  5-HT threshold in both 
blood and cerebrospinal fluid o f  experimental animals with 
subarachnoid hemorrhage leads to a multifold enhance­
ment o f  the vascular constriction effect o f  nervous fibres 
and their reflection on the cerebral vessels underlying the 
brain vasoconstriction (13). In migraine patients during the 
period between the seizures there is an increase by two 
times but during the seizure itself by four times o f  the 
plasma levels o f  norepinephrine, serum dopamine, beta-hy- 
droxylase, systolic and diastolic arterial blood pressure and 
heart rate in comparison with these parameters in healthy
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controls. These abnormalities indicate the involvement of 
the sympathetic nervous system.
After its liberation from enterochromaffin cells, mainly 
from platelets, 5-HT interacts with cardiovascular tissues. 
The indol amine is a substance proved in the heart and 
blood vessels o f  mammals including man. The amount o f 
5-HT is by 6 times smaller in the heart than that o f 
norepinephrine. The physiological role o f  5-HT remains in­
sufficiently clarified yet; however, because o f its relation 
with the amines it could be involved in the pathogenesis of 
certain heart diseases.
Clinical symptoms in migraine 
and cardiovascular diseases
More than 60 years ago, Fitz-Haugh (8) noted that approxi­
mately 27 per cent o f migraine patients complained from 
the side o f  the heart (pain, fits o f  palpitation, etc.). These 
symptoms may accompany the fits o f  migraine or represent 
their equivalents, ht such cases, die audtor suggested the 
nomination o f  'overintestinal migraine’ that was used in 
practice for a while by various authors. Tltis syndrome is 
extraordinarily rare being observed a total o f  two times 
among 1000 patients (19). Such generalizations are an ex­
pression o f  a particularly careful selection o f  die patients 
with cardiovascular complaints. Leon-Solomayor de­
scribed 12 cases, 10 females and two males (12). In the 
course o f  long lasting diseases in migraine patients he es­
tablished during die fits a series o f  symptoms such as palpi­
tation, angina pectoris, tachycardia, bradycardia, anxiety 
and feeling o f fear. The ECG-examination during die fit 
demonstrated non-specific changes o f  T-wave and either 
elevation, or decrease o f  ST-segment. The coronary 
arteriography o f 6 patients failed to demonstrate any vascu­
lar alterations at all. This author supposed that the fit re­
sulted from a spasm o f the coronary vessels ('coronary mi­
graine'). Besides during the fit o f migraine one has de­
scribed paroxysmal disorders o f the heart rhydim emerging 
independendy o f headache. Already in 1925, attention was 
paid to die relation between the paroxysmal tachycardia 
and migraine (21). A female patient presenting with crises 
o f  paroxysmal tachycardia not only duiing die fit o f mi­
graine but also in die fit-free period was reported ( 17). ECG 
changes were established in 13 o f  49 migraine patients only 
(2). The following findings were found out in 57 migraine 
patients examined during the disease-free intervals and in 
10 ones examined during die fits: i) normocardia in 61,4 per 
cent but tendency towards bradycardia and tachycardia - in
38.6 per cent o f die cases; ii) abnormal ECG recordings in
38.6 per cent o f  the cases; iii) myocardial ischemia, low 
voltage o f the curves, high amplitudes o f  T- and P-waves 
belonged to the most common abnormal signs (1). ECG 
data do not suggest any essential pathological aberrations in 
the heart activity related with the pathogenesis o f migraine. 
They are, however, necessary for the administration and 
control o f treatment, especially in adult and senile patients, 
in hypertensive patients as well as when ergotamme and 
contemporary antimigraine drugs are used.
Smyth and Winter (20) note that the observations o f  heart 
rate, respiration and skin galvanic response do not reveal 
any typical features in migraine patients. Therefore, the pri­
mary mechanisms o f migraine do not reflect considerably 
on die peripheral and autonomic activity. Belov and 
Uzunov (1) conclude diat in migraine die adrenergic reac­
tivity estimated by means o f skin-vegetative tests is higher 
tiian die cholinergic one. However, ECG data indicate re­
verse correlations: more common bradycardia tiian tachy­
cardia. Besides there is ECG evidence o f certain 
hyperkaliemia despite the absent electrolyte disbalance. 
These changes could be related with the abnormalities of 
the vegetative innervation and probable biochemical distur­
bances that require further investigations within the com­
plex o f migraine-accompanying pathophysiological mech­
anisms.
The relation between hypertension and migraine lias been 
first suggested by Walker in 1959 (22). The study o f 375 
migraine patients o f whom 60 males and 315 females dem­
onstrates a tendency towards an increasing of the arterial1 
pressure in dependence on the duration o f migraine (4). 
Odier authors report that anamnesis o f hypertension is by 
twofold more common in patients with classical migraine 
(6).
Relationship between antimigraine drugs 
and cardiovascular disorders
Some antimigraine drugs induce spasm o f the coronary 
vessels and could explain the occurrence oi 
medicamentous complications such as chest pain and fre­
quent heart attacks in some migraine patients. The drugs 
represent a risk factor for the preliminarily damaged arterial 
vessels in heart diseases such as Prinzmetal's angina or an­
gina pectoris leading to vasospasm in response to treatmeni 
although there are no coronary scleroses at all ( 11,15). The 
patients presenting with high cholesterol levels or with arte­
rial hypertension should be examined prior to the 
antimigraine treatment in order to avoid the aforemen­
tioned complications. The cases with organ donation and 
the reflection o f the new medicaments on the arterial ves­
sels are o f  interest, indeed. Testing o f old vessels by* 
ergotamine, methysergid and their metabolites such ai 
methylergotamine as well as by the new means such as 
sumatriptan, naratriptan, zolmitriptan and rizatriptan estab 
lishes that this effect is less significant concerning the new 
drugs, relatively long lasting (90-min long) concerning the 
old means such as dihydroergotamine and eigotamine bus 
short lasting (up to 30-min long) concerning the triptanes 
The administration o f sumatriptan leads to the feeling о 
stress and severity in the chest, chest pain and symptoms ol 
angina pectoris in 50 per cent o f  the patients (15,19).
The new class o f 5-HT IB/Id antagonists and ergotamini 
as well can induce vasoconstriction by stimulation o f  5-Hl 
receptors o f  the peripheral vessels. The cardiovascular el 
feet o f  Zomig in a dose o f  20 mg and o f ergotamme in a 
dose o f 2 mg orally alone or in combination was studied in 
a double-blind, placebo-controlled trial o f 12 healthy sub 
jects. Arterial blood pressure, systolic blood pressure of the
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thumb and hand, bioimpedance cardiography, brachial ar­
terial diameter and velocity o f peripheral blood flow by 
Doppler were examined. Both drugs lead to a small extent 
to vasoconstriction, increasing o f the diastolic blood pres­
sure and die speed o f the blood flow as well as reduction of 
the arterial diameter o f the thumb and hand. There is no sig­
nificant difference in the heart minute volume, heart rate 
and ECG changes. Both medicaments are well tolerated in 
their combination as ergotamine does not show any signifi­
cant effect on zolmitriptan pharmacokinetics (7,23). Tire 
therapeutic effect on the fit o f migraine, from a modem 
viewpoint, is based on the hypothesis about the presence of 
two kinds of serotonin receptors - o f lb  and Id types that 
mediate the antimigraine effect in acute fits. Tire different 
receptors lead to a differentiated approach in the treatment 
of migraine. For instance, ergotamines interrupt the fit o f 
migraine; however, they affect some other receptors such 
as adrenergic and dopamine ones. The new drugs such as 
sumatriptan and noratriptan act specifically on type 1 sero­
tonin receptors. Their influence is related with shunting of 
the dilated vessels during the fit o f migraine more outlined 
in those in tire head and less in tire cranium and eyes result­
ing in cerebral ischemia. Similar mechanisms are detected 
in the heart consisting in vasoconstriction and closure o f 
collateral channels thus inducing an unfavourable side ef­
fect. In this way tire contraindications emerge. They are tire 
following: pregnancy, peripheral vascular diseases, cardio­
vascular diseases such as angina pectoris, heart attacks, cor­
onary spasm and uncontrolled hypertension. Besides 
sumatriptan should not be combined with ergotamine in 
migraine (13.15,23).
The patients with pulmonary symptoms occur equally often 
with cardiovascular symptoms or risk factors. Tire risk o f 
pains in the chest and neck in tire course o f  sumatriptan 
therapy is more seldom when compared with that in cardio­
vascular diseases (8,11). This fact raises the hypothesis that 
these are the reason for heart ischemia after sumatriptan 
therapy, lire latter induces ECG changes consisting o f tran­
sitory ischemia as well as angina pectoris, arrhythmia, 
myocardial infarction and death in isolated cases when the 
drug is applied for the first time (9). However, neither the 
pathogenesis o f tire cardiovascular diseases, nor their rela- 
nonsliip with the administered treatment and tire primary 
disease has become clear. A clinical case o f a 56-year-old 
female patient with migraine was presented. She developed 
the symptoms o f a myocardial infarction soon after the in­
troduction of sumatriptan although her anamnesis was nor- 
mal. After catheterization for ischemic heart disease no 
pathological alterations were detected suggesting that 
sumatriptan has induced coronary spasm and myocardial 
infarction (11).
The investigations of the risk factors for cardiovascular 
complications demonstrate arterial hypertension in 36 per 
cent, cardiopathy in 24 per cent, diabetes mellitus in 12 per 
cent, tobacco smoking in 8 per cent, polycythemia in 4 per 
cent, hyperlipemia in 16 per cent, and chronic ethylism in 4 
per cent. The anamnesis reveals migraine without evidence 
of epileptic seizures in 29 per cent and ECG changes in 12
per cent, o f which nonspecific ones in 24 per cent o f the 
cases (20-22). In a 34-year old woman with aortic and mi­
tral valve defect after ergotamine misuse the picture of 
dyspnea was established after a long history o f  a peripheral 
vascular disease. Heart insufficiency advanced rapidly and, 
surgically, a fibroblast proliferation o f the mitral valve was 
detected.
There is evidence o f cardiovascular diseases combined 
with a risk o f  migraine fits. In this aspect, associations were 
drawn o f parallel relationships between the patients with 
migraine and those with cardiovascular diseases. The fa­
milial and individual anamnesis in a group o f patients with 
cardiovascular diseases and migraine show a significant 
risk o f  mutual risk existence o f  these two disease groups. In 
two females a paradoxical cardioembolic stroke during a 
migraine fit defining the migraine as risk factors (18). A fa­
milial predisposition between migraine and Raynaud's dis­
ease as a risk factor for the manifestation o f migraine fits. 
Because sumatriptan leads to coronary spasm in the pa­
tients with coronary risk its therapeutic application should 
carefully be specified. The investigation o f 186 patients 
with systemic lupus erythematosus demonstrates a risk for 
the occurrence o f migraine fits in 39 per cent while the 
screening o f  the general population detects a risk o f  13-18 
per cent for the females and o f 2-6 per cent for the males. It 
is not influenced by the systemic treatment o f the systemic 
lupus erythematosus, neither provokes migraine fits. These 
authors suggest the search for symptoms in this disease 
( 10). Other authors interviewed 85 males and 15 females at 
a mean age o f  54,7 years and demonstrated the develop­
ment o f  an acute myocardial infarction. There was evi­
dence o f myocardial infarctions in 6 per cent o f  the cases. 
O f them, migraine fits were present in 66,7 per cent along 
with anamnesis o f  angina pectoris while in the patients 
without migraine this occurred in 17 per cent o f the cases 
only (14).
It could be concluded that the low relative share o f myocar­
dial infarctions in migraine patients along with the higher 
share o f the angina pectoris results from the coronary 
spasm accompanying every migraine fit and from the in­
creased arterial resistance. Ischemia plays an important role 
in these cases and requires tire discussion o f  an adequate 
therapeutic and protective approach.
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